EVC
RVNC

Eidelman Virant Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

Eidelman Virant Capital’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,450
Closed -$239K – 207
2020
Q4 		$239K Buy
+8,450
New +$239K 0.1% 132